Biotech Values

[iwfal]

EXAS -

I can think of some things EXAS might do if they wanted to quantify cumulative sensitivity. They could test patients several times at very short intervals and use mathematical models to extrapolate to series of tests separated by longer intervals.

Exactly. This is one of the possible methods I mentioned earlier in this thread that would bear on their otherwise unsubstantiated claims of cumulative sensitivity.

And, to pile on, if this is one of the dumber threads I'd love to see some of the ones thought to be 'bright'.